133 related articles for article (PubMed ID: 36441909)
1. PET Imaging of P2X7 Receptor (P2X7R) for Neuroinflammation with Improved Radiosynthesis of Tracer
Huang G; Qiu Y; Bi L; Wei H; Li G; Li Z; Ye P; Yang M; Shen Y; Liu H; Wang L; Jin H
ACS Chem Neurosci; 2022 Dec; 13(23):3464-3476. PubMed ID: 36441909
[TBL] [Abstract][Full Text] [Related]
2. Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [
Huang G; Lu X; Qiu Y; Bi L; Ye P; Yang M; Shen Y; Jin H; Han J
Bioorg Med Chem; 2022 Nov; 73():116996. PubMed ID: 36126443
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
[TBL] [Abstract][Full Text] [Related]
4. Characterization of
Territo PR; Meyer JA; Peters JS; Riley AA; McCarthy BP; Gao M; Wang M; Green MA; Zheng QH; Hutchins GD
J Nucl Med; 2017 Mar; 58(3):458-465. PubMed ID: 27765863
[TBL] [Abstract][Full Text] [Related]
5. PET Imaging of the P2X7 Ion Channel with a Novel Tracer [
Berdyyeva T; Xia C; Taylor N; He Y; Chen G; Huang C; Zhang W; Kolb H; Letavic M; Bhattacharya A; Szardenings AK
Mol Imaging Biol; 2019 Oct; 21(5):871-878. PubMed ID: 30632003
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.
Han J; Liu H; Liu C; Jin H; Perlmutter JS; Egan TM; Tu Z
Nucl Med Commun; 2017 May; 38(5):372-382. PubMed ID: 28338530
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Positron Emission Tomography Imaging with P2X7 Receptor-Specific Radioligand
Fu Z; Lin Q; Xu Z; Fu W; Shi D; Cheng Y; Yang T; Liu G; Shi H; Cheng D
ACS Chem Neurosci; 2022 Dec; 13(23):3512-3522. PubMed ID: 36383137
[TBL] [Abstract][Full Text] [Related]
8. [
Van Weehaeghe D; Koole M; Schmidt ME; Deman S; Jacobs AH; Souche E; Serdons K; Sunaert S; Bormans G; Vandenberghe W; Van Laere K
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2051-2064. PubMed ID: 31243495
[TBL] [Abstract][Full Text] [Related]
9. Increased uptake of the P2X7 receptor radiotracer
Morgan J; Moreno O; Alves M; Baz Z; Menéndez Méndez A; Leister H; Melia C; Smith J; Visekruna A; Nicke A; Bhattacharya A; Ceusters M; Henshall DC; Gómez-Vallejo V; Llop J; Engel T
Epilepsia; 2023 Feb; 64(2):511-523. PubMed ID: 36507708
[TBL] [Abstract][Full Text] [Related]
10. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [
Kong Y; Cao L; Wang J; Zhuang J; Liu Y; Bi L; Qiu Y; Hou Y; Huang Q; Xie F; Yang Y; Shi K; Rominger A; Guan Y; Jin H; Ni R
ACS Chem Neurosci; 2024 Jun; 15(11):2112-2120. PubMed ID: 38776461
[TBL] [Abstract][Full Text] [Related]
11. Ankylosing spondylitis PET imaging and quantifications via P2X7 receptor-targeting radioligand [
Zhang S; Qiu Y; Huang L; Bi L; Guo Y; You K; Huang G; Wang Y; Lu H; Jin H; Shan H
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3589-3601. PubMed ID: 37466648
[TBL] [Abstract][Full Text] [Related]
12. PET imaging of P2X
Beaino W; Janssen B; Kooijman E; Vos R; Schuit RC; O'Brien-Brown J; Kassiou M; van Het Hof B; Vugts DJ; de Vries HE; Windhorst AD
J Neuroinflammation; 2020 Oct; 17(1):300. PubMed ID: 33054803
[TBL] [Abstract][Full Text] [Related]
13. P2X7 PET Radioligand
Fu Z; Lin Q; Hu B; Zhang Y; Chen W; Zhu J; Zhao Y; Choi HS; Shi H; Cheng D
J Nucl Med; 2019 Jul; 60(7):930-936. PubMed ID: 30655332
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
Kolb HC; Barret O; Bhattacharya A; Chen G; Constantinescu C; Huang C; Letavic M; Tamagnan G; Xia CA; Zhang W; Szardenings AK
J Nucl Med; 2019 Aug; 60(8):1154-1159. PubMed ID: 30733317
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical study on [
Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
[TBL] [Abstract][Full Text] [Related]
16.
Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?
Schmidt S; Isaak A; Junker A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674884
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and initial in vitro characterization of a new P2X7R radioligand [
Gao M; Wang M; Glick-Wilson BE; Meyer JA; Peters JS; Territo PR; Green MA; Hutchins GD; Zarrinmayeh H; Zheng QH
Appl Radiat Isot; 2019 Feb; 144():10-18. PubMed ID: 30476885
[TBL] [Abstract][Full Text] [Related]
19. Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis.
Beaino W; Janssen B; Kooij G; van der Pol SMA; van Het Hof B; van Horssen J; Windhorst AD; de Vries HE
J Neuroinflammation; 2017 Dec; 14(1):259. PubMed ID: 29273052
[TBL] [Abstract][Full Text] [Related]
20. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.
Zhang L; Hu K; Shao T; Hou L; Zhang S; Ye W; Josephson L; Meyer JH; Zhang MR; Vasdev N; Wang J; Xu H; Wang L; Liang SH
Acta Pharm Sin B; 2021 Feb; 11(2):373-393. PubMed ID: 33643818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
